Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland.
The present study was conducted to estimate the direct losses due to Neospora caninum in Swiss dairy cattle and to assess the costs and benefits of different potential control strategies. A Monte Carlo simulation spreadsheet module was developed to estimate the direct costs caused by N. caninum, with and without control strategies, and to estimate the costs of these control strategies in a financial analysis. The control strategies considered were "testing and culling of seropositive female cattle", "discontinued breeding with offspring from seropositive cows", "chemotherapeutical treatment of female offspring" and "vaccination of all female cattle". Each parameter in the module that was considered to be uncertain, was described using probability distributions. The simulations were run with 20,000 iterations over a time period of 25 years. The median annual losses due to N. caninum in the Swiss dairy cow population were estimated to be euro 9.7 million euros. All control strategies that required yearly serological testing of all cattle in the population produced high costs and thus were not financially profitable. Among the other control strategies, two showed benefit-cost ratios (BCR) >1 and positive net present values (NPV): "Discontinued breeding with offspring from seropositive cows" (BCR=1.29, NPV=25 million euros ) and "chemotherapeutical treatment of all female offspring" (BCR=2.95, NPV=59 million euros). In economic terms, the best control strategy currently available would therefore be "discontinued breeding with offspring from seropositive cows".
Häsler
Barbara
B
Swiss Federal Veterinary Office, Schwarzenburgstrasse 155, CH-3003 Bern, Switzerland.
Regula
Gertraud
G
Stärk
Katharina D C
KD
Sager
Heinz
H
Gottstein
Bruno
B
Reist
Martin
M
D000818:Animals; D001947:Breeding; D002417:Cattle; D002418:Cattle Diseases / Q000191:economics / Q000517:prevention & control* / Q000635:transmission; D003048:Coccidiosis / Q000191:economics / Q000517:prevention & control / Q000635:transmission / Q000662:veterinary*; D003049:Coccidiostats / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003612:Dairying / Q000191:economics* / Q000379:methods; D037901:Euthanasia, Animal; D005260:Female; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control / Q000662:veterinary*; D009010:Monte Carlo Method; D018688:Neospora / Q000472:pathogenicity; D013557:Switzerland; D014611:Vaccination / Q000191:economics / Q000662:veterinary
D003049:Coccidiostats